Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RadNet, Inc. filings document material-event disclosures for operating results, financial condition, governance, capital structure, and corporate actions tied to its diagnostic imaging and digital health businesses. Recent Form 8-K reports furnish quarterly results press releases and exhibits, including segment information for Imaging Centers and Digital Health.
The company’s proxy materials address board matters, executive compensation, and shareholder voting items. Other filings include leadership and compensatory-arrangement disclosures, prospectus supplements under automatic shelf registration statements for common stock resale registrations, and acquisition-related share issuance matters associated with RadNet’s health informatics expansion.
RadNet, Inc. (RDNT) Form 144 notice: The filer proposes to sell 5,000 shares of common stock through Raymond James (9595 Wilshire Blvd., Suite 801, Beverly Hills, CA) with an approximate aggregate market value of $358,950. The proposed sale date is 08/27/2025 on NASDAQ. The filing reports 76,916,062 shares outstanding. All 5,000 shares were acquired as stock awards from the issuer on 01/28/2021 (864 shares), 02/18/2021 (1,205 shares) and 01/05/2022 (2,931 shares), and payment/nature of acquisition is listed as Stock Award. The form contains no reportable sales in the past three months. Several standard filer and issuer identification fields (CIK, issuer name and contact details) are not provided in the visible content.
Insider sale recorded: Cornelis Wesdorp, listed as President & CEO, Digital Health and a director of RadNet, Inc. (RDNT), reported selling 1,500 shares of common stock on 08/19/2025 at a price of $66.98 per share. After the sale he beneficially owned 54,495 shares in a direct form. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
RadNet insider transaction: The company's Chief Information Officer reported a sale of 65,598 shares of RadNet common stock at $67.50 per share, leaving beneficial ownership of 138,198 shares after the reported transaction. The Form 4 indicates the filing was submitted by a single reporting person and signed by an attorney-in-fact.
RadNet, Inc. (RDNT) filed a Form 144 reporting a proposed sale of 70,000 common shares with an aggregate market value of $4,452,000.00, to be sold approximately on 08/15/2025 on NASDAQ. The filing shows 74,036,993 shares outstanding, and the shares to be sold were acquired entirely through stock option exercises on multiple dates between 2016 and 2024. Each acquisition was paid by cash/check. The broker listed is Commonwealth Financial Network in Waltham, MA. The filer certifies there are no undisclosed material adverse facts and notes no securities were sold in the past three months.
RadNet insider sale recorded: The filing shows David Jeffrey Katz, Executive Vice President and Chief Legal Officer of RadNet, Inc. (RDNT), sold 17,000 shares of common stock on 08/13/2025 at a weighted average price of $68.31 per share. After the sale, Mr. Katz beneficially owned 86,774 shares, held directly. The filing notes the reported sale occurred in multiple transactions with prices ranging from $68.02 to $68.54. The form is signed by an attorney-in-fact on behalf of the reporting person.
RadNet reported higher second-quarter revenue and a return to quarterly profitability, but a six-month operating loss left common shareholders with a year-to-date deficit. Total service revenue for the three months ended June 30, 2025 was $498,230,000, up from $459,714,000 a year earlier, driven by growth across commercial and Medicare payors. The company recorded quarterly net income of $23,034,000, with net income attributable to RadNet common stockholders of $14,454,000 and diluted EPS of $0.19.
For the six months ended June 30, 2025 RadNet reported a consolidated net loss of $(6,703,000), and a net loss attributable to RadNet common stockholders of $(23,472,000) (diluted EPS $(0.32)). Operating cash flow improved to $161,829,000 for the six months. The company completed acquisitions, including See-Mode Technologies for approximately $28.7 million with contingent consideration of $8.8 million, and goodwill totaled $751,514,000 at June 30, 2025. Total long-term debt was $1,077,251,000.
RadNet, Inc. furnished a press release reporting its financial results for the second quarter ended June 30, 2025, with that press release included as Exhibit 99.1 to this Current Report. The filing identifies the disclosure under Item 2.02 (Results of Operations and Financial Condition) and also includes an interactive XBRL cover page as Exhibit 104. The company states the information is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into other filings except by specific reference.
Aside from the notice that Q2 2025 results were released, the report contains no financial figures, metrics, or commentary on performance. The report was executed on behalf of the registrant by Mark Stolper, Chief Financial Officer, and confirms the company’s common stock trades as RDNT on NASDAQ. Investors must consult Exhibit 99.1 for the detailed Q2 financial results.
RadNet EVP and Chief Science Officer Alma Gregory Sorensen reported a charitable donation of 5,600 shares of common stock on June 17, 2025. The transaction was executed at $0 as it was a gift (Transaction Code: G).
Following the transaction, Sorensen maintains direct beneficial ownership of 1,165,345 shares of RadNet common stock. The filing indicates that Sorensen serves in dual roles as both a Director and Executive Officer (EVP, Chief Science Officer) of the company.
Key Transaction Details:
- Transaction Type: Charitable Donation
- Direct Ownership Maintained
- No derivative securities were involved in this transaction
- Filing was signed by Jose Gamez as Attorney-in-Fact on June 18, 2025